GSWM
IGC icon

Golden State Wealth Management’s IGC Pharma IGC Stock Holding History

Golden State Wealth Management’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-225
Closed – – 529
2020
Q1 		$0 Buy
+225
New +$125 ﹤0.01% 991
2019
Q4 		– Sell
-225
Closed – – 468
2019
Q3 		$0 Hold
225
– – ﹤0.01% 1101
2019
Q2 		$0 Buy
+225
New +$318 ﹤0.01% 1115

Other funds holding IGC

CFA
Carroll Financial Associates Charlotte, North Carolina $1.88B AUM 20.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
DP
Dearborn Partners Chicago, Illinois $1.85B AUM 6.59% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
SFS
Sowell Financial Services North Little Rock, Arkansas $3.06B AUM 30.02% 1-Year Est. Return

Golden State Wealth Management's IGC Position: Q2 2020 in Review

Golden State Wealth Management sold out of IGC Pharma (IGC) in Q2 2020, closing a stake of 225 shares.

Golden State Wealth Management first reported a position in IGC in Q2 2019 and held it in 3 quarters. The position peaked at $0 in Q1 2020. 21 funds tracked by Wall St. Rank hold IGC as of Q2 2020.

  • Golden State Wealth Management reported no remaining IGC Pharma position as of Q2 2020 after selling out during the quarter.
  • Golden State Wealth Management sold 225 IGC Pharma shares in Q2 2020.
  • Golden State Wealth Management first reported a position in IGC Pharma in Q2 2019 and held it in 3 quarters.
  • Golden State Wealth Management's IGC Pharma position peaked at $0 in Q1 2020.
  • 21 funds tracked by Wall St. Rank held IGC Pharma as of Q2 2020.

Based on Golden State Wealth Management's 13F filing for Q2 2020, filed 11 Aug 2020.